MedTrace Logo

Training Intensity After Coronary Bypass Grafting

NCT00226733 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-05-18

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of high and moderate intensity exercise training after coronary bypass surgery. The subjects are randomised to training at either 60-70% or 85-95% of their maximal capacity daily for four weeks. Primary outcome measure is change in maximal aerobic capacity, measured as change in maximal oxygen consumption, after the training period. Secondary outcome measures are change in quality of life, heart rate variability, ultrasound measures of the heart and blood variables, including endothelian markers.

Conditions

  • Coronary Artery Bypass

Interventions

BEHAVIORAL

Exercise training

Interval exercise training with high intensity five days per week for four weeks.

BEHAVIORAL

Exercise training

Exercise training with moderate intensity, five days per week for four weeks.

Sponsors & Collaborators

  • Stiftelsen Helse og Rehabilitering

    collaborator OTHER

  • Landsforeningen for hjerte og lungesyke (LHL)

    collaborator UNKNOWN

  • Røros Rehabiliteringssenter

    collaborator UNKNOWN

  • St. Olavs Hospital

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Stig A Slørdahl, Dr.med · NTNU, Institutt for sirkulasjon og bildediagnostikk

  • Trine T Moholdt, MS · NTNU, Institutt for sirkulasjo og bildediagnostikk

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2007-03-31
Completion
2007-03-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00226733 on ClinicalTrials.gov